Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06904807
PHASE1

A Phase I Study to Evaluate LIFE-001

Sponsor: LifeMine Therapeutics

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if LIFE-001 is safe and tolerable for healthy adult volunteers.

Official title: A Phase I, Single Ascending and Multiple Ascending Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LIFE-001

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-04-07

Completion Date

2026-11-13

Last Updated

2026-03-19

Healthy Volunteers

Yes

Interventions

DRUG

LIFE-001

Single dose of LIFE-001 between 10mg and 750mg administered subcutaneously

DRUG

Placebo

Single dose of placebo comparator administered subcutaneously

DRUG

LIFE-001 MAD

Four doses of LIFE-001 between 50mg and 750mg administered subcutaneously seven days apart

DRUG

Placebo MAD

Four doses of placebo comparator administered subcutaneously seven days apart

Locations (1)

Veritus Research Pty Ltd

Bayswater, Victoria, Australia